ALK and neoplasm: Although IHC seems to be a valid method to screen ALK expression in this malignancy, these findings imply the need of a careful and combined analysis of both the genetic and protein status of ALK, as a gene rearrangements may have different consequences to tumour cell growth and survival compared to copy number gain.